NIH to evaluate remdesivir treatment for COVID during pregnancy

WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]

SARS-CoV-2 Infection and COVID-19 During Pregnancy: A

Remdesivir - Wikipedia

Clinical outcomes of hospitalized COVID-19 patients treated with

SARS-CoV-2 infection in pregnancy: A systematic review and meta

COVID-19 in people with rheumatic diseases: risks, outcomes

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid

Remdesivir Now Approved for COVID Outpatients, Too

Diagnosis and management of covid-19 in pregnancy

Remdesivir for pregnancy: A systematic review of antiviral therapy

Two Years into the COVID-19 Pandemic: Lessons Learned

Evaluation & Management of COVID-19 in Pregnancy

Summary of Guidance for Minimizing the Impact of COVID-19 on

The Incidence, Severity, and Management of COVID-19 in Critically

Cureus Compassionate Use of Remdesivir in Pregnancy: A Case